NeuroCytonix
Developer of non-invasive regenerative protocols and an investigational medical device that deliver low-energy electromagnetic and radiofrequency signals to targeted brain regions. Operates a clinical research center in Monterrey, Mexico that follows ICH E6(R3) Good Clinical Practice standards and conducts randomized and open-label clinical studies in cerebral palsy and other neurological conditions. Holds regulatory acknowledgement from the Mexican authority for a cerebral palsy treatment protocol and is pursuing additional regulatory authorizations. The company publishes case reports describing individual patient outcomes, including reports of improved quality of life with no adverse events observed.
Industries
Nr. of Employees
small (1-50)
Products
Investigational imaging-targeted electromagnetic stimulation device
A clinical investigational device composed of configurable emitter arrays and sensors that deliver focused low-energy radiofrequency and magnetic fields to specified brain regions guided by MRI; used to deliver imaging-guided investigational protocols.
NeuroCytotron
A medical device that delivers precise levels of radiofrequency waves to damaged or nonfunctioning cells with the goal of activating cell signaling pathways that regenerate brain cells and repair their broken communication networks.
Cerebral Palsy Protocol
A non-invasive personalized precision treatment protocol for cerebral palsy that uses a combination of magnetic fields and low-energy radio waves to activate neuron regrowth and repair damaged neural connections in the brain.
Functional Neurogenesis Stimulation
A non-invasive treatment protocol utilizing precisely calculated doses of low-energy electromagnetic signals and radiofrequency pulses to promote neural tissue regeneration and restore broken neural connections in the brain.
Investigational imaging-targeted electromagnetic stimulation device
A clinical investigational device composed of configurable emitter arrays and sensors that deliver focused low-energy radiofrequency and magnetic fields to specified brain regions guided by MRI; used to deliver imaging-guided investigational protocols.
NeuroCytotron
A medical device that delivers precise levels of radiofrequency waves to damaged or nonfunctioning cells with the goal of activating cell signaling pathways that regenerate brain cells and repair their broken communication networks.
Cerebral Palsy Protocol
A non-invasive personalized precision treatment protocol for cerebral palsy that uses a combination of magnetic fields and low-energy radio waves to activate neuron regrowth and repair damaged neural connections in the brain.
Functional Neurogenesis Stimulation
A non-invasive treatment protocol utilizing precisely calculated doses of low-energy electromagnetic signals and radiofrequency pulses to promote neural tissue regeneration and restore broken neural connections in the brain.
Services
Personalized 28-day, one-hour-per-day investigational protocol using calibrated electromagnetic and radiofrequency signals targeted to MRI-identified brain regions; delivered on-site at the Monterrey clinical research center for investigational purposes.
Design and operate randomized and open-label clinical studies, including participant screening, informed consent, safety monitoring, outcome assessment, and manuscript preparation.
Personalized 28-day, one-hour-per-day investigational protocol using calibrated electromagnetic and radiofrequency signals targeted to MRI-identified brain regions; delivered on-site at the Monterrey clinical research center for investigational purposes.
Design and operate randomized and open-label clinical studies, including participant screening, informed consent, safety monitoring, outcome assessment, and manuscript preparation.
Expertise Areas
- Clinical trial management
- Non-invasive neurostimulation therapies
- Neuroimaging and imaging biomarkers
- Pediatric neurology clinical research
Key Technologies
- Magnetic Resonance Imaging (MRI)
- Diffusion tensor imaging (DTI) and tractography
- Brain volumetry
- Electroencephalography (EEG)
News & Updates
Company posted an important notice to the NeuroCytonix community.
Announcement that the Mexican regulatory authority authorized launch of a neuro-restorative treatment program in Mexico.
Company launched a clinical trial to study its neuroregenerative protocol in autism spectrum disorder.
Publication that the company completed a randomized clinical trial evaluating its investigational protocol in children with cerebral palsy.
Clinical story page reporting an individual pediatric patient treated with the investigational protocol, describing improved quality of life with no adverse events observed.
Company posted an important notice to the NeuroCytonix community.
Announcement that the Mexican regulatory authority authorized launch of a neuro-restorative treatment program in Mexico.
Company launched a clinical trial to study its neuroregenerative protocol in autism spectrum disorder.
Publication that the company completed a randomized clinical trial evaluating its investigational protocol in children with cerebral palsy.
Clinical story page reporting an individual pediatric patient treated with the investigational protocol, describing improved quality of life with no adverse events observed.